Cancer management in patients with end-stage renal disease
Significant improvements in the management of patients with end-stage renal disease (ESRD) who are on chronic renal replacement therapy (CRRT), has led to an increase prevalence of this population among older Americans. Since cancer is also common in the elderly, oncologists are likely to be faced w...
Gespeichert in:
Veröffentlicht in: | Oncology (Williston Park, N.Y.) N.Y.), 2005-08, Vol.19 (9), p.1199-212; discussion 1212-4 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Significant improvements in the management of patients with end-stage renal disease (ESRD) who are on chronic renal replacement therapy (CRRT), has led to an increase prevalence of this population among older Americans. Since cancer is also common in the elderly, oncologists are likely to be faced with patients who suffer from both cancer and ESRD. There is a paucity of information regarding issues surrounding the optimal management of such patients, especially those needing chemotherapy. This review surveys the relevant problems oncologists may encounter in such patients and summarizes the available literature on chemotherapeutic management of common cancers. The reader is strongly urged to consult the original references for details of chemotherapy administration prior to use in an individual patient. |
---|---|
ISSN: | 0890-9091 |